OpenEvidence
PrivateLast Round
Growth Equity
Jul 19, 2026
Est. Valuation
$20B
Total Funding Raised
$985M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
OpenEvidence is a healthcare technology company that develops an AI-powered medical search engine and clinical decision support platform for healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Clinical Trials, Drug Discovery, NLP & Conversational AI
Business Model
B2B2C
Customer Profile
Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OpenEvidence Comparables
Compare OpenEvidence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wolters Kluwer | 82% | |
| NoveList | 79% | |
| Athenahealth | 78% |
OpenEvidence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 19, 2026 | ||||
| Series D | Jan 21, 2026 | ||||
| Series C | Oct 20, 2025 | ||||
| Series B | Jul 15, 2025 | ||||
| Series A | Feb 19, 2025 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
BID | |||||
OFFER | |||||
BID | |||||
BID | |||||
OFFER | |||||
BID |
Key People
Founding team and executive leadership
OpenEvidence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series E |
| Breyer Capital | Series D |
| DST Global | Series D |
| Blackstone | Series C, Series D |
| ICONIQ Capital | Series D |
| GV | Series D, Series C, Series B |
| Conviction | Series B, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
$250M round led by Andreessen Horowitz and Byers Capital.
- Jul 19, 2026
$200M raised at $20B post-money valuation.
Recent news
Latest coverage and updates
- partners_withSep 23, 2026
OpenEvidence Inc. partnered with Resolve to Save Lives on Jan 1st '26.
- partners_withSep 11, 2026
OpenEvidence Inc. partnered with Minc#Nimc on Sep 11th '26.
- launchesSep 3, 2026
OpenEvidence Inc. launched family of medical AI search models on Sep 3rd '26.
- is_developingSep 3, 2026
OpenEvidence Inc. is developing medical specialist AI models.
- is_developingSep 3, 2026
OpenEvidence Inc. is developing medical superintelligence on Jan 1st '26.
OpenEvidence Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about OpenEvidence's valuation, stock price, and market status.
Is OpenEvidence a public or private company?
OpenEvidence is a private company.
What is the current stock price of OpenEvidence?
OpenEvidence is a private company with no public stock price. Caplight tracks OpenEvidence's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is OpenEvidence worth (valuation)?
OpenEvidence's valuation is estimated at $12.0B based on funding round data.
Can I buy OpenEvidence stock?
OpenEvidence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OpenEvidence's last funding round?
OpenEvidence's most recent funding round was Series D on January 21, 2026.
Who are the main investors in OpenEvidence?
Key investors in OpenEvidence include DST Global, GV, Thrive Capital, Sequoia Capital, Kleiner Perkins.
Will OpenEvidence IPO soon?
No public IPO plans have been announced for OpenEvidence.
How can I track OpenEvidence secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OpenEvidence's secondary market activity and sign up for updates.